← Back to Search

Cell phone intervention arm for Latent Tuberculosis Infection

Phase < 1
Waitlist Available
Led By Dr. Richard Lester, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 or 9 months
Awards & highlights

Study Summary

This study will examine the impact of use of mobile phones and text messaging on adherence to treatment for patients with latent TB infection. Half (50%) of the 350 anticipated study participants will receive weekly text messages inquiring on their health status in relation to their prescribed treatment, while the other half (50%) will not receive weekly text messages at all. Medical adherence will be assessed by monthly blood-work, clinic visits and by interviewing patients at each of these visits. The investigators hypothesis is that enhanced communication with a health care provider, via a structured cell phone SMS text messaging based program (WelTel), will result in a 15% improvement in the proportion of patients who successfully complete their LTBI treatment regimens.

Eligible Conditions
  • Latent Tuberculosis Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 or 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 or 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Successful completion of LTBI treatment regimens.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cell phone intervention armExperimental Treatment1 Intervention
Upon consent, participants will be randomly assigned to receive either 1) standard of care (9 months of INH or 4 months of RIF) and weekly SMS text messages via mobile phone or 2) standard of care (9 months of INH or months of RIF) without weekly SMS text messages via mobile phone.
Group II: Non-interventionActive Control1 Intervention
Participants will only receive standard of care

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,418 Previous Clinical Trials
2,466,768 Total Patients Enrolled
British Columbia Cancer AgencyOTHER
171 Previous Clinical Trials
90,161 Total Patients Enrolled
Dr. Richard Lester, MDPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment
2012. "TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01549457.
All > Tb
~27 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top